Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily AG member 1 (OR2AG1) is a member of the large olfactory receptor family, which consists of G protein-coupled receptors (GPCRs) characterized by a 7-transmembrane domain structure. These receptors are responsible for detecting odorant molecules in the nasal epithelium, initiating a signal transduction cascade that results in the perception of smell. The OR2AG1 gene encodes a protein involved in odorant signal recognition, sharing structural features with neurotransmitter and hormone receptors. Notably, this gene can behave as a segregating pseudogene in the population, meaning some alleles encode functional protein while others are non-functional. While OR2AG1 may be associated with certain non-olfactory syndromes, there is currently no evidence of it being directly targeted by therapeutic drugs or used as a biomarker in clinical settings.
No approved drugs or mechanistic studies targeting this receptor beyond endogenous odorant molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily AG member 1 (OR2AG1).